Mangoceuticals adds renowned tech entrepreneur and investor, aaron andrew, to advisory board

Dallas, texas, may 25, 2023 (globe newswire) -- mangoceuticals, inc. (nasdaq:mgrx) (“mangorx” or the “company”), a company focused on developing, marketing and selling a variety of men's health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction (ed) drug branded “mango,” is pleased to announce that it has added serial technology entrepreneur and investor, aaron andrew, to its advisory board (the “advisory board”).
MGRX Ratings Summary
MGRX Quant Ranking